Compare Bio Protocol (BIO) vs Zerebro (ZEREBRO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Zerebro — how do they compare? Bio Protocol trades at Rp514.37 (market cap Rp1,15T, Rp260,42M 24h volume), while Zerebro trades at Rp639.29 (market cap Rp637,82M, Rp153,03M 24h volume). The key difference: Bio Protocol is far larger — about 1803× Zerebro's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 999,9M / 1B ZEREBRO (100%) for Zerebro. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Zerebro for 8 Days on average.
| BIO | ZEREBRO | |
|---|---|---|
Market Cap | Rp1,15T | Rp637,82M |
Volume (24h) | Rp260,42M | Rp153,03M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 999,9M / 1B ZEREBRO (100%) |
Typical Hold Time | 16 Days | 8 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
ZEREBRO is currently trading at Rp645.046 with a market cap of Rp644.89M, exhibiting a bearish technical signal despite bullish moving averages. The token trades near its R1 resistance at Rp642, with key support at Rp600. With 100% of its 1M max supply in circulation and an average hold time of 8 days, on-chain activity appears limited. No recent protocol upgrades or significant ecosystem developments have been reported.
The overall outlook is cautious due to bearish momentum and low liquidity. Key opportunities include a potential rebound from oversold RSI levels if buying pressure increases. Major risks involve high volatility from thin order books, lack of recent development activity, and susceptibility to market manipulation given its small market cap.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Zerebro
Zerebro is an autonomous AI system designed to create, distribute, and analyze content across decentralized and social platforms. It operates without direct human oversight and influences cultural and financial narratives through self-propagating content that blends fiction and reality, a phenomenon known as hyperstition.
Read more on ZEREBRO →
